Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Radioiodine Therapy for Hyperthyroidism
source: The New England Journal of Medicine
year: 2011
authors: Douglas S. Ross
summary/abstract:A 37-year-old woman receives a diagnosis of Graves’ disease and is treated with methimazole for 1 year. After completing this treatment, she presents with recurrent symptoms of hyperthyroidism. Radioiodine ablation is recommended.
organization: Massachusetts General Hospital, USADOI: 10.1056/NEJMct1007101
read more full text
myBinderRelated Content
-
Most Patients With Graves’ Disease Treated With Antithyroid Drugs Eventually Require Additional TherapiesGraves’ disease is the most common cau...
-
Relation Between Therapy for Hyperthyroidism and the Course of Graves’ OphthalmopathyBackground: The chief clinical characte...
-
Effects of Treatment Modalities for Graves’ Hyperthyroidism on Graves’ Orbitopathy: A 2015 Italian Society of En...Graves’ disease is the most frequent f...
-
Selenium in Graves Hyperthyroidism and OrbitopathyPurpose: To review the in vitro and in ...
-
Early, Effective Control of Graves’ Disease Improves Survival, Regardless of TreatmentAn early and intensive control of hypert...
-
Hyperthyroidism and Graves’ DiseaseWhat is the Thyroid? The thyroid is a s...
-
Hyperthyroidism: Graves’ OphthalmopathyGraves' ophthalmopathy, also called thyr...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Brought to you by
Supported through an independent
educational grant by
Facebook
Google